🇺🇸 FDA
Pipeline program

SV-BR-1-GM

BRI-ROL-001

Phase 3 mab active

Quick answer

SV-BR-1-GM for Breast Cancer is a Phase 3 program (mab) at BriaCell Therapeutics with 2 ClinicalTrials.gov record(s).

Program details

Company
BriaCell Therapeutics
Indication
Breast Cancer
Phase
Phase 3
Modality
mab
Status
active

Clinical trials